Effect of low-dose droperidol on the QT interval during and after general anesthesia: A placebo-controlled study

Anesthesiology

Volumn 102, Issue 6, 2005, Pages 1101-1105

  White, Paul F ^b   Song, Dajun ^b   Abrao, Joao ^a,b   Klein, Kevin W ^b   Navarette, Bryan ^b  

^a Curso de Medicina   (Brazil)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; DROPERIDOL; SODIUM CHLORIDE;

ADULT; ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HUMAN; INTRAOPERATIVE PERIOD; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADULT; ANESTHESIA, GENERAL; DOUBLE-BLIND METHOD; DROPERIDOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE COMPLICATIONS; LONG QT SYNDROME; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 19744369642     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200506000-00007     Document Type: Article

References (30)

1. Tang J, Watcha MF, White PF: A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996; 83:304-13
2. Fortney JT, Gan TJ, Gracryk S, Wetchler B, Melson T, Khalil S, McKenzie R, Parrillo S, Glass PSA, Moote C, Wermeling D, Parasuraman TV, Duncan B, Creed MR: A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. Anesth Analg 1998; 86:731-8
3. Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS, Gan TJ: Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. ANESTHESIOLOGY 2000; 92:931-3
4. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trankler S, Kredel M, Biedler A, Sessler DI, Roewer N: A factorial trial of six interventions for prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350:2441-51
5. Chang N, Simone A, Schultheis L, Rappaport B: Reviewing case reports and the droperidol warning: FDA response (letter). Anesth Analg 2003; 97:1542
6. Shafer SL: Safety of patients reason for FDA black box warning on droperidol (letter). Anesth Analg 2004; 98:551-2
7. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A: FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: Is it justified? (letter). ANESTHESIOLOGY 2002; 97:287
8. Young D: Black-box warning for droperidol surprises pharmacists. Am J Health Pharm 2002; 59:494, 497, 502-4
9. White PF: Droperidol: A cost-effective antiemetic for over thirty years. Anesth Analg 2002; 95:789-90
10. Dershwitz M: Droperidol: should the black box be light gray? J Clin Anesth 2002; 14:598-603
11. Habib AS, Gan TJ: Food and Drug Administration black box warning on the perioperative use of droperidol: A review of the cases. Anesth Analg 2003; 96:1377-9
12. Scuderi PE: Droperidol: Many questions, few answers. ANESTHESIOLOGY 2003; 98:289-90
13. Bailey P, White PF: Droperidol editorial: Making a mountain out of a mole hill! ANESTHESIOLOGY 2003; 99:760-1
14. Guy JM, Andre-Fouet X, Porte J, Bertrand M, Lamaud M, Verneyre H: Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol. Ann Cardiol Angiol (Paris) 1991; 40:541-5
15. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J: Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994; 79:983-6
16. Zhang Y, Luo Z, White PF: A model for evaluating droperidol's effect on the median QTc interval. Anesth Analg 2004; 98:1330-5
17. Bazett HC: An analysis of the time-relation of electrocardiograms. Heart 1920; 7:353-67
18. Zsigmond EK: Neurolept and dissociative anesthesia. Textbook of Intravenous Anesthesia. Edited by White PF. London, Williams & Wilkins, 1997, pp 393-403
19. Dershwitz M: There should be a threshold dose for the FDA black-box warning on droperidol. Anesth Analg 2003; 97:1542-3
20. Benedict CR, Arbogast R, Martin L, Patton L, Morrill B, Hahne W: Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996; 28:53-9
21. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HK, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde AM: Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management parts I and II. Circulation 1999; 99:518-28
22. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HK, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde AM: Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management part III. Circulation 1999; 99:674-81
23. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D: Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 2000; 295:614-20
24. Sadanaga T, Sadanaga F, Yao H, Fujishima M: Hart rate dependent modification of the QTc cut-off values can improve accurate evaluation of QT prolongation. Am J Cardiol 2004; 93:772-5
25. Brouwer J, Van Den Berg MP, Grobbee DE, Haaksma J, Wilde AA: Diagnostic performance of various QTc interval formulas in a large family with long QT syndrome type 3: Bazett's formula not so bad after all... Ann Noninvasive Electrocardiol 2003; 8:269-74
26. Liu B, Juurlink DN: Drugs and the QT interval: Caveat doctor. N Engl J Med 2004; 351:1053-96
27. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramer MR, Watcha M: Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97:62-71
28. Watcha MF: The cost-effective management of postoperative nausea and vomiting. ANESTHESIOLOGY 2000; 92:931-3
29. White PF: Prevention of postoperative nausea and vomiting: A multimodal solution to a persistent problem. N Engl J Med 2004; 350:2511-2
30. Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013-22